Financial Snapshot: Analyzing Omeros Corporation (OMER)’s Key Ratio Metrics

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Omeros Corporation (NASDAQ: OMER) was $5.39 for the day, up 3.26% from the previous closing price of $5.22. In other words, the price has increased by $3.26 from its previous closing price. On the day, 0.67 million shares were traded. OMER stock price reached its highest trading level at $5.555 during the session, while it also had its lowest trading level at $5.17.

Ratios:

Our analysis of OMER’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.76 and its Current Ratio is at 4.76.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on December 08, 2022, Downgraded its rating to Neutral and sets its target price to $2 from $12 previously.

On November 08, 2022, BofA Securities Downgraded its rating to Underperform which previously was Neutral and also lowered its target price recommendation from $8 to $3.

BofA Securities Downgraded its Buy to Neutral on June 08, 2022, whereas the target price for the stock was revised from $12 to $4.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 17 ’23 when Demopulos Gregory A MD bought 15,000 shares for $1.68 per share. The transaction valued at 25,200 led to the insider holds 123,945 shares of the business.

Demopulos Peter A MD bought 10,000 shares of OMER for $15,300 on Nov 15 ’23. The Director now owns 208,516 shares after completing the transaction at $1.53 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OMER now has a Market Capitalization of 321891872 and an Enterprise Value of 544282496.

Stock Price History:

Over the past 52 weeks, OMER has reached a high of $5.68, while it has fallen to a 52-week low of $0.92. The 50-Day Moving Average of the stock is 30.71%, while the 200-Day Moving Average is calculated to be 61.91%.

Shares Statistics:

OMER traded an average of 345.46K shares per day over the past three months and 412860 shares per day over the past ten days. A total of 61.13M shares are outstanding, with a floating share count of 55.36M. Insiders hold about 4.46% of the company’s shares, while institutions hold 43.68% stake in the company. Shares short for OMER as of 1721001600 were 12884008 with a Short Ratio of 37.30, compared to 1718323200 on 13236401. Therefore, it implies a Short% of Shares Outstanding of 12884008 and a Short% of Float of 23.26.

Most Popular